Bausch health companies inc. (BHC)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Revenues
Service and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74

62

55

35

33

26

15

12

10

12

0

0

0

Total revenues

8,597

8,601

8,498

8,425

8,401

8,380

8,422

8,505

8,610

8,724

8,964

9,224

9,411

9,674

10,028

10,336

10,648

10,447

9,911

9,181

8,489

8,206

8,047

7,532

6,587

5,769

4,625

3,968

3,692

3,480

3,212

2,929

2,718

2,427

2,289

1,897

1,526

1,181

879

864

0

0

0

Expenses
Cost of alliance and service revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

Selling, general and administrative

2,600

2,554

2,512

2,478

2,469

2,473

2,486

2,495

2,512

2,582

2,608

2,646

2,658

2,810

2,888

2,924

2,939

2,700

2,481

2,287

2,117

2,026

1,952

1,803

1,545

1,305

1,059

892

820

756

699

646

610

572

551

477

372

276

193

182

0

0

0

Research and Development Expense (Excluding Acquired in Process Cost)

476

471

477

461

438

413

383

357

357

361

364

384

414

421

423

424

381

334

297

255

240

246

246

236

194

156

117

87

80

79

75

73

74

65

67

63

69

68

73

104

0

0

0

Amortization of Intangible Assets Excluding Amortization Allocated to Revenues Cost of Good Sold

1,844

1,897

1,954

2,137

2,390

2,644

2,917

2,916

2,798

2,690

2,573

2,580

2,630

2,673

2,642

2,657

2,569

2,257

1,942

1,656

1,437

1,427

1,475

1,993

1,931

1,902

1,839

1,147

1,054

928

822

742

646

557

482

380

298

219

135

121

0

0

0

Goodwill impairments

-

-

109

109

-

2,322

2,213

2,525

2,525

312

1,361

0

0

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset Impairment Charges

86

75

183

239

527

568

519

836

620

714

657

399

544

422

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring Charges

15

31

34

33

36

22

26

29

40

52

96

110

112

132

166

221

345

362

318

304

303

382

453

635

546

462

477

277

253

267

171

144

142

97

102

182

157

140

101

17

0

0

0

Acquired in-process research and development costs

-

-

-

-

-

-

-

-

2

-

5

36

37

34

129

111

0

-

0

0

-

20

65

169

165

153

274

154

0

-

0

0

-

109

32

32

40

89

0

0

0

-

-

Acquisition-related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

15

22

30

36

77

73

78

78

46

50

38

32

40

38

0

-

0

0

-

-

0

Legal settlements and related fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-40

0

0

-

0

-

-

-

-

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset

-46

-12

-16

6

32

9

15

234

277

289

328

81

25

13

27

32

28

23

6

6

15

14

-19

19

18

29

26

-13

-2

5

13

26

20

10

0

0

0

-

-

0

-

-

-

Other Operating Income (Expense), Net

-1,440

-1,414

1

26

34

20

-232

78

97

348

491

165

192

-73

-61

-91

-313

-295

0

0

0

-

196

-237

-239

-287

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

8,839

8,804

7,600

7,739

8,217

10,764

11,153

11,315

11,000

8,622

8,390

9,551

9,832

10,240

10,578

9,575

9,626

8,920

7,946

6,979

6,274

6,205

6,428

7,489

6,757

6,179

5,356

3,778

3,557

3,400

3,040

2,674

2,431

2,127

2,032

1,879

1,578

1,291

881

730

0

0

0

Operating Income (Loss)

-242

-203

898

686

184

-2,384

-2,731

-2,810

-2,390

102

574

-327

-421

-566

-549

761

1,022

1,527

1,965

2,201

2,215

2,001

1,619

43

-169

-409

-731

189

135

79

172

255

286

299

256

17

-51

-110

-2

134

0

0

0

Interest income

15

12

11

12

12

11

12

12

12

12

11

11

10

8

7

5

4

4

3

3

4

5

6

8

8

8

8

6

6

6

4

4

4

4

3

2

1

1

0

0

0

0

0

Interest expense

1,602

1,612

1,635

1,649

1,675

1,685

1,719

1,758

1,782

1,840

1,859

1,870

1,883

1,836

1,801

1,751

1,692

1,563

1,355

1,193

1,022

971

1,009

999

935

844

744

611

534

481

413

385

367

334

292

216

143

84

41

34

0

0

0

Write-down of deferred financing charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-59

-42

-84

-84

-99

-119

-132

-133

-85

-122

-65

-64

-64

0

0

0

0

-20

-56

-56

-56

-130

-129

-137

-137

-65

-47

-41

-41

-20

-5

-13

-28

-36

0

0

0

-

-

-

-

-

-

Foreign exchange and other

-5

8

17

8

-4

23

38

57

105

107

42

21

-6

-41

0

-31

-37

-103

-180

-199

-201

-144

-68

-10

-24

-9

-2

-8

-3

19

44

42

48

26

0

4

4

0

0

0

0

0

0

Gain on investments, net (Note 23)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

5

5

5

1

2

2

1

23

22

22

17

-3

-5

0

0

0

-

-

Loss before benefit from income taxes

-1,893

-1,837

-793

-1,027

-1,582

-4,154

-4,532

-4,632

-4,140

-1,741

-1,297

-2,229

-2,364

-2,435

-2,342

-1,016

-704

-155

664

1,046

1,232

1,054

424

-1,093

-1,254

-1,314

-1,510

-459

-435

-394

-196

-95

-34

-18

-74

-234

-239

-236

-54

120

0

0

0

Loss on auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on disposal of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on auction rate security settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Income Tax Expense (Benefit)

-6

-54

-185

-116

31

-10

-1,242

-2,993

-3,336

-4,145

-2,677

-1,090

-958

-27

-60

-4

55

133

63

221

233

174

-78

-348

-398

-450

-433

-360

-305

-278

-225

-157

-174

-177

-147

-58

-40

-28

82

25

0

0

0

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-1,887

-1,783

-608

-911

-1,613

-4,144

-3,290

-1,639

-804

2,404

1,380

-1,139

-1,406

-2,408

-2,282

-1,011

-759

-288

600

825

998

880

503

-745

-856

-863

-980

0

0

-

0

-

-

-

-

-

-

-

-

0

0

0

0

Net income attributable to noncontrolling interest

1

5

8

6

6

4

1

1

1

0

4

4

1

1

-2

0

4

4

3

2

-2

-1

0

1

4

2

1

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-1,888

-1,788

-616

-917

-1,619

-4,148

-3,291

-1,640

-805

2,404

1,376

-1,143

-1,407

-2,409

-2,280

-1,012

-763

-292

596

822

1,001

881

502

-746

-861

-866

-1,079

-98

-130

-116

28

62

140

159

-104

0

0

-

0

-

-

-

-

(Loss) earnings per share attributable to Bausch Health Companies Inc.
Basic (in dollars per share)

-

-

-

-

-

-

-

-

-7.36

1.46

3.71

-0.11

1.80

-1.49

-3.49

-0.88

-1.08

-1.13

0.14

-0.15

0.29

1.50

0.82

0.38

-0.07

-

-2.92

0.04

-

-

0.03

-0.07

-

0.18

0.13

0.19

0.02

0.02

-1.27

0.21

-0.02

0.25

0.15

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-7.36

1.46

3.69

-0.11

1.79

-1.49

-3.49

-0.88

-1.08

-1.12

0.14

-0.15

0.28

1.47

0.81

0.37

-0.07

-

-2.92

0.03

-

-

0.02

-0.07

-

0.17

0.13

0.17

0.02

0.02

-1.27

0.21

-0.02

0.25

0.15

Basic and diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share)

-0.43

-

-0.14

-0.49

-0.15

-

-1.00

-2.49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.09

-

-

-

-0.04

-

-

-

-

-

-

-

-

-

-

Weighted-average common shares
Basic (in shares)

-

-

-

-

-

-

-

-

350

350

350

350

349

349

349

345

344

344

344

344

336

336

335

335

334

-

333

308

-

-

304

304

-

308

302

303

303

303

163

158

158

158

158

Diluted (in shares)

-

-

-

-

-

-

-

-

350

354

352

350

350

349

349

345

344

332

351

344

343

348

341

341

334

-

333

314

-

-

311

304

-

317

322

331

332

300

163

161

158

158

158

Weighted Average Number of Shares Outstanding, Basic and Diluted

353

-

352

352

351

-

351

351

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

305

-

-

-

307

-

-

-

-

-

-

-

-

-

-

Cash dividends declared per share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1.00

0.09

0.09

0.09

0.09

0.09

Product sales
Revenues

8,486

8,489

8,389

8,317

8,295

8,271

8,306

8,384

8,484

8,595

8,830

9,087

9,276

9,536

9,890

10,195

10,501

10,292

9,747

9,021

8,321

8,046

7,899

7,383

6,452

5,640

4,550

3,897

3,576

3,288

3,000

2,718

2,505

2,255

2,089

1,720

1,421

1,133

848

835

0

0

0

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

2,278

2,297

2,267

2,269

2,273

2,309

2,354

2,431

2,482

2,506

2,524

2,523

2,536

2,572

2,636

2,622

2,644

2,532

2,370

2,282

2,181

2,178

2,336

2,351

2,065

1,846

1,400

1,056

965

905

815

761

738

683

712

611

505

395

235

223

0

0

0

Other revenues
Revenues

111

112

109

108

106

109

116

121

126

129

134

137

135

138

138

140

147

155

164

159

168

160

147

149

134

129

140

117

142

191

137

148

157

136

166

150

89

35

19

16

0

0

0

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

54

53

50

46

42

42

42

42

43

42

42

42

41

39

38

43

48

53

55

57

58

58

59

59

57

58

-9

-9

-7

64

90

79

66

12

0

0

0

-

-

-

-

-

-